Metrics as of 10/16/2026, 08:52 AM (Berlin time), refresh in progress.
MindWalk Holdings Stock
MindWalk Holdings Corp.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Jennifer Lynne Bath
- Employees
- 76
- Market cap
- $62 M
- IPO
- 07/01/2002
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its…
MindWalk Holdings stock: price history
1D
-6.4%
1W
-12.7%
1M
+15.9%
6M
-1.5%
YTD
-28.0%
1Y
-20.1%
2Y
+133.5%
5Y
-80.1%
10Y
–
Next earnings date
Next earnings date
21/12/2026 (in 65 days)
Volatility around earnings
~22% stronger price swings than usual
Ask the agents about MindWalk Holdings
Analyst assessment of MindWalk Holdings
PRICE TARGET LOW
US$5.00
CONSENSUS
US$5.00
MEDIAN
US$5.00
PRICE TARGET HIGH
US$5.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 19/05/2026
MindWalk Holdings stock metrics
P/E
-5.07
P/B
12.54
EV/EBITDA
-4.99
RETURN ON EQUITY
-89.4%
NET MARGIN
-158.7%
DEBT/EQUITY
0.5
DIVIDEND YIELD
0.0%
AS OF
31/07/2026
Free float & liquidity
FREE FLOAT
90.6%
FLOAT SHARES
42,661,217
AVG. DAILY VOLUME (30D)
304,555
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about MindWalk Holdings stock
What does MindWalk Holdings do?
MindWalk Holdings Corp. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Jennifer Lynne Bath, the company employs around 76 people.
The IPO was on 07/01/2002; the stock trades on NASDAQ under the ticker HYFT.
What do analysts say about MindWalk Holdings stock?
2 analysts rate the stock, the consensus is Buy (as of 19/05/2026).
The average price target is US$5.00, ranging from US$5.00 to US$5.00, with a median of US$5.00.
This is an external assessment, not a statement by Market Jury.
When does MindWalk Holdings report next?
The next earnings date is 21/12/2026.
Around past earnings, price swings were roughly 22% stronger than usual.
Does MindWalk Holdings pay a dividend?
No, MindWalk Holdings currently does not pay a dividend.
Which stocks are comparable to MindWalk Holdings?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get MindWalk Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess MindWalk Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.